CC BY-NC-ND 4.0 · Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery 2022; 41(01): e70-e75
DOI: 10.1055/s-0041-1730370
Review Article

Paroxysmal Sympathetic Hyperactivity in Patients Victims of Traumatic Brain Injury: Literature Review

Hiperatividade simpática paroxística em pacientes vítimas de trauma cranioencefálico: Revisão da literatura
1   Medical Faculty, Universidade Federal do Paraná, Curitiba, PR, Brazil
,
2   Medical Faculty, Faculdade de Medicina do Centro Universitário de Maringá, Maringá, PR, Brazil
,
3   Medical Faculty, Universidade Federal de Sergipe, Aracaju, SE, Brazil
,
4   Neurosurgery Service, Hospital Urgência de Sergipe, Preceptor of the Neurosurgery Residency at Surgery Hospital Charitable Foundation, Aracaju, SE, Brazil
› Author Affiliations

Abstract

The present literature review aims to present the physiology of paroxysmal sympathetic hyperactivity (PSH) as well as its clinical course, conceptualizing them, and establishing its diagnosis and treatment. Paroxysmal sympathetic hyperactivity is a rare syndrome, which often presents after an acute traumatic brain injury. Characterized by a hyperactivity of the sympathetic nervous system, when diagnosed in its pure form, its symptomatologic presentation is through tachycardia, tachypnea, hyperthermia, hypertension, dystonia, and sialorrhea. The treatment of PSH is basically pharmacological, using central nervous system suppressors; however, the nonmedication approach is closely associated with a reduction in external stimuli, such as visual and auditory stimuli. Mismanagement can lead to the development of serious cardiovascular and diencephalic complications, and the need for neurosurgeons and neurointensivists to know about PSH is evident in order to provide a fast and accurate treatment of this syndrome.

Resumo

O presente artigo de revisão de literatura tem como objetivo apresentar a fisiologia da hiperatividade simpática paroxística (HPS), bem como sua evolução clínica, conceituando-as, estabelecendo seu diagnóstico e o tratamento. A HPS é uma síndrome rara, que geralmente se apresenta após uma lesão cerebral traumática aguda. A HPS é caracterizada por uma hiperatividade do sistema nervoso simpático, e quando diagnosticada na sua forma pura, apresenta sintomatologia através de taquicardia, taquipneia, hipertermia, hipertensão, distonia e sialorreia. O tratamento da HPS é basicamente farmacológico, por meio do uso de supressores do sistema nervoso central, porém a abordagem não medicamentosa está intimamente associada à redução de estímulos externos, como visuais e auditivos. A má gestão pode levar ao desenvolvimento de complicações cardiovasculares e diencefálicas graves, e a necessidade de neurocirurgiões e neurointensivistas saberem sobre o HSP para fornecer um tratamento rápido e preciso dessa síndrome é evidente.



Publication History

Received: 08 June 2020

Accepted: 22 February 2021

Article published online:
17 December 2021

© 2021. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. Autonomic dysfunction presenting as postural tachycardia syndrome following traumatic brain injury. Cardiol J 2010; 17 (05) 482-487
  • 2 Patel MB, McKenna JW, Alvarez JM. et al. Decreasing adrenergic or sympathetic hyperactivity after severe traumatic brain injury using propranolol and clonidine (DASH After TBI Study): study protocol for a randomized controlled trial. Trials 2012; 13: 177
  • 3 Godbolt AK, Stenberg M, Jakobsson J. et al. Subacute complications during recovery from severe traumatic brain injury: frequency and associations with outcome. BMJ Open 2015; 5 (04) e007208
  • 4 Hughes JD, Rabinstein AA. Early diagnosis of paroxysmal sympathetic hyperactivity in the ICU. Neurocrit Care 2014; 20 (03) 454-459
  • 5 Inoue A, Ebina M, Atsumi T, Ariyoshi K. Refractory paroxysmal sympathetic hyperactivity following brain injury in a pregnant woman that dramatically improved after delivery. Acute Med Surg 2015; 3 (03) 268-271
  • 6 Lemke DM. Sympathetic storming after severe traumatic brain injury. Crit Care Nurse 2007; 27 (01) 30-37 , quiz 38
  • 7 Kirk KA, Shoykhet M, Jeong JH. et al. Dysautonomia after pediatric brain injury. Dev Med Child Neurol 2012; 54 (08) 759-764
  • 8 Bower RS, Sunnarborg R, Rabinstein AA, Wijdicks EFM. Paroxysmal sympathetic hyperactivity after traumatic brain injury. Neurocrit Care 2010; 13 (02) 233-234
  • 9 Magalhães FN, Paiva WS, Andrade AF. et al. Considerações sobre a síndrome da disfunção autonômica pós traumatismo cranioencefálico: fisiopatologia e tratamento. Braz Neurosurg 2012; 31 (02) 75-80
  • 10 Gao B, Pollock JA, Hinson HE. Paroxysmal sympathetic hyperactivity in hemispheric intraparenchymal hemorrhage. Ann Clin Transl Neurol 2014; 1 (03) 215-219
  • 11 Compton E. Paroxysmal sympathetic hyperactivity syndrome following traumatic brain injury. Nurs Clin North Am 2018; 53 (03) 459-467
  • 12 Hinson HE, Puybasset L, Weiss N. et al; Neuro Imaging for Coma Emergence, Recovery (NICER) Consortium. Neuroanatomical basis of paroxysmal sympathetic hyperactivity: a diffusion tensor imaging analysis. Brain Inj 2015; 29 (04) 455-461
  • 13 Meyfroidt G, Baguley IJ, Menon DK. Paroxysmal sympathetic hyperactivity: the storm after acute brain injury. Lancet Neurol 2017; 16 (09) 721-729
  • 14 Perkes IE, Baguley IJ. Current understanding of dysautonomia after severe acquired brain injury. ACNR 2008; 8 (01) 10-11
  • 15 Godo S, Irino S, Nakagawa A. et al. Diagnosis and management of patients with paroxysmal sympathetic hyperactivity following acute brain injuries using a consensus-based diagnostic tool: A single institutional case series. Tohoku J Exp Med 2017; 243 (01) 11-18
  • 16 Thomas A, Greenwald BD. Paroxysmal sympathetic hyperactivity and clinical considerations for patients with acquired brain injuries: A narrative review. Am J Phys Med Rehabil 2019; 98 (01) 65-72
  • 17 Godoy DA, Panhke P, Guerrero Suarez PD, Murillo-Cabezas F. Paroxysmal sympathetic hyperactivity: An entity to keep in mind. Med Intensiva 2019; 43 (01) 35-43
  • 18 Domínguez-Jiménez E, Piña-Ramírez BM, García-Ramírez JL. et al. Hiperactividad simpática paroxística: Descripción de dos casos pediátricos y revisión de la literatura. Revista Mexicana de Neurosciencia. 2012; 13 (02) 98-103
  • 19 Lee S, Jun GW, Jeon SB, Kim CJ, Kim JH. Paroxysmal sympathetic hyperactivity in brainstem-compressing huge benign tumors: clinical experiences and literature review. Springerplus 2016; 5: 340
  • 20 Hilz MJ, Wang R, Markus J. et al. Severity of traumatic brain injury correlates with long-term cardiovascular autonomic dysfunction. J Neurol 2017; 264 (09) 1956-1967
  • 21 Esterov D, Greenwald BD. Autonomic Dysfunction after mild traumatic brain injury. Brain Sci 2017; 7 (08) 100
  • 22 Blackman JA, Patrick PD, Buck ML, Rust Jr RS. Paroxysmal autonomic instability with dystonia after brain injury. Arch Neurol 2004; 61 (03) 321-328
  • 23 Verma R, Giri P, Rizvi I. Paroxysmal sympathetic hyperactivity in neurological critical care. Indian J Crit Care Med 2015; 19 (01) 34-37
  • 24 Fernández-Ortega JF, Prieto-Palomino MA, Muñoz-Lopez A, Hernández-Sierra B, Séller-Pérez G, Quesada-García G. Crisis disautonómicas tras traumatismo craneoencefálico grave. Med Intensiva 2004; 28 (07) 376-379
  • 25 Peng Y, Zhu H, Chen H. et al. Dexmedetomidine attenuates acute paroxysmal sympathetic hyperactivity. Oncotarget 2017; 8 (40) 69012-69019
  • 26 Baguley IJ, Perkes IE, Fernandez-Ortega JF, Rabinstein AA, Dolce G, Hendricks HT. Consensus Working Group. Paroxysmal sympathetic hyperactivity after acquired brain injury: consensus on conceptual definition, nomenclature, and diagnostic criteria. J Neurotrauma 2014; 31 (17) 1515-1520
  • 27 Ghatala MZ, Murugan S, Mahadevan S, Booma S. A rare case of diencephalic seizures secondary to hemorrhagic stroke. India Journal of Clinical Practice. 2014; 24 (11) 1043-1045
  • 28 Totikov A, Boltzmann M, Schmidt SB, Rollnik JD. Influence of paroxysmal sympathetic hyperactivity (PSH) on the functional outcome of neurological early rehabilitation patients: a case control study. BMC Neurol 2019; 19 (01) 162
  • 29 Burton JM, Morozova OM. Calming the storm: Dysautonomia for the pediatrician. Curr Probl Pediatr Adolesc Health Care 2017; 47 (07) 145-150
  • 30 Letzkus L, Keim-Malpass J, Anderson J, Kennedy C. Paroxysmal sympathetic hyperactivity in children: An exploratory evaluation of nursing interventions. J Pediatr Nurs 2017; 34: e17-e21
  • 31 Ahl R, Thelin EP, Sjölin G. et al. β-Blocker after severe traumatic brain injury is associated with better long-term functional outcome: a matched case control study. Eur J Trauma Emerg Surg 2017; 43 (06) 783-789
  • 32 Pedavally S, Fugate JE, Rabinstein AA. Serotonin syndrome in the intensive care unit: clinical presentations and precipitating medications. Neurocrit Care 2014; 21 (01) 108-113
  • 33 Tang Q, Wu X, Weng W. et al. The preventive effect of dexmedetomidine on paroxysmal sympathetic hyperactivity in severe traumatic brain injury patients who have undergone surgery: a retrospective study. PeerJ 2017; 5: e2986